<DOC>
	<DOCNO>NCT00578981</DOCNO>
	<brief_summary>To develop decision aid support decision use ( use ) bisphosphonates postmenopausal woman risk osteoporotic fracture , assess impact decision aid start six month adherence bisphosphonates .</brief_summary>
	<brief_title>Osteoporosis Choice Decision Aid Use Bisphosphonates Postmenopausal Women</brief_title>
	<detailed_description>Bisphosphonates reduce fracture risk patient osteoporosis . However , many patient may start adhere bisphosphonates , consequently lose independence , quality , length life . We hypothesize decision aid efficiently improve patient education communication provider fracture risk , use bisphosphonates reduce risk , improve quality treatment decision . We anticipate patient become involved decision-making process decision consistent patient ' value health care goal . We expect lead increased bisphosphonate start adherence improve patient outcome .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Female , postmenopausal woman age 50 90 . Have bone mineral density ( BMD ) evaluation result TScore &lt; 1.0 . Have followup appointment provider area Family Medicine ( FM ) , Primary Care Internal Medicine ( PCIM ) , POM . Have major barrier ( i.e. , severe hearing impairment , dementia , require interpreter , etc . ) participation share decisionmaking ( per provider 's assessment ) Enrollment open female diverse racial background . Currently take bisphosphonate . Not available 6 month followup phone call .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Osteoporosis , age-related</keyword>
	<keyword>Osteoporosis , Postmenopausal</keyword>
	<keyword>Bone Loss</keyword>
	<keyword>Low Bone Density</keyword>
</DOC>